Vitality Watch

Dossier pubmed observational 01-nov-2026
Human cohort, case-control, or epidemiological association

Possible sarcopenia, abdominal obesity, and all-cause mortality in middle-aged and older adults with chronic kidney disease: a dual-cohort study.

Key claim: Low muscle strength independently predicts all-cause mortality in middle-aged and older adults with chronic kidney disease, whereas abdominal adiposity provides no independent or incremental prognostic value beyond handgrip strength.

Abstract

BACKGROUND: Possible sarcopenia (low muscle strength) is a strong predictor of mortality in chronic kidney disease (CKD). While abdominal obesity is prevalent, whether it predicts mortality or modifies the association between muscle weakness and mortality remains controversial. We investigated their independent and joint associations with all-cause mortality in CKD. METHODS: This study analyzed adults with CKD aged ≥45 years from CHARLS (n = 1005) and NHANES (n = 1070). Participants were categorized into four phenotypes: NPS/NAO (neither condition), NPS/AO (abdominal obesity alone), PS/NAO (possible sarcopenia alone), and PS/AO (both conditions). Mortality risk was evaluated using multivariable Cox models and restricted cubic splines. RESULTS: PS/NAO was associated with elevated all-cause mortality (adjusted HR in CHARLS: 1.980, 95% CI 1.333-2.941; NHANES: 2.191, 1.194-4.020). The estimate for PS/AO was less precise and did not reach statistical significance (CHARLS: 1.288, 0.711-2.333; NHANES: 1.171, 0.661-2.075). Direct comparisons and interaction analyses revealed no evidence that abdominal obesity modified the mortality risk associated with possible sarcopenia. No significant association was observed between NPS/AO and mortality. Handgrip strength showed an inverse linear association with mortality, whereas waist circumference provided neither independent nor incremental prognostic value. CONCLUSIONS: Possible sarcopenia independently predicts all-cause mortality in CKD, though this association did not retain statistical significance in CHARLS when restricted to participants with eGFR <60 mL/min/1.73 m. Waist circumference provides no incremental prognostic value beyond handgrip strength, and the study was underpowered to characterize the concurrent phenotype. Prognostic evaluation in CKD should focus on routine muscle strength assessment rather than abdominal adiposity. CLINICAL TRIAL NUMBER: not applicable.

Why this matters

Low muscle strength independently predicts all-cause mortality in middle-aged and older adults with chronic kidney disease, whereas abdominal adiposity provides no independent or incremental prognostic value beyond handgrip strength.

Source

Link

Briefing card

Possible sarcopenia, abdominal obesity, and all-cause mortality in middle-aged and older adults with chronic kidney disease: a dual-cohort study.
Stage: observational · pubmed · 01-nov-2026

Low muscle strength independently predicts all-cause mortality in middle-aged and older adults with chronic kidney disease, whereas abdominal adiposity provides no independent or incremental prognostic value beyond handgrip strength.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.archger.2026.106474

build build 880 · 2bcef25 · 2026-11-18